Home/Filings/4/0001209191-19-000588
4//SEC Filing

Lafond Kevin G 4

Accession 0001209191-19-000588

CIK 0001107421other

Filed

Jan 1, 7:00 PM ET

Accepted

Jan 2, 9:16 PM ET

Size

8.0 KB

Accession

0001209191-19-000588

Insider Transaction Report

Form 4
Period: 2018-12-29
Lafond Kevin G
Vice Pres., Treasurer, & CAO
Transactions
  • Tax Payment

    Common Stock

    2018-12-30$1.66/sh13,100$21,74657,767 total
  • Tax Payment

    Common Stock

    2018-12-29$1.66/sh17,667$29,32770,867 total
  • Tax Payment

    Common Stock

    2018-12-31$1.87/sh9,334$17,45548,433 total
Footnotes (1)
  • [F1]Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock grants.

Issuer

ZIOPHARM ONCOLOGY INC

CIK 0001107421

Entity typeother

Related Parties

1
  • filerCIK 0001429559

Filing Metadata

Form type
4
Filed
Jan 1, 7:00 PM ET
Accepted
Jan 2, 9:16 PM ET
Size
8.0 KB